Home › Companies › Biotechnology, Health Care, Life Science, Machine Learning, Medical › Ceretype Neuromedicine
Ceretype Neuromedicine
Ceretype Neuromedicine is a next-generation fMRI brain biomarker platform to improve drug discovery and patient care in neuropsychiatry
Ceretype Neuromedicine is active in the biotechnology, health care, life science, machine learning, medical space based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2020.
Its activity falls under biotechnology, health care, life science, machine learning, medical; the profile below is assembled from public directory data.
The company is recorded as being based in Greater Boston Area, East Coast, New England, Northeastern US.
Directory data places it at the Seed stage.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $4.4M in funding.
| Sector | Biotechnology, Health Care, Life Science, Machine Learning, Medical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $4,350,000 |
Website: ceretype.com
Browse related
Sign in to view the contact information we hold for Ceretype Neuromedicine.
Create a free account
Create a free account